Medicine & Life Sciences
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
20%
7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid
78%
Acetates
14%
Acids
25%
Alkylation
19%
Amides
17%
androstane
23%
Androstenes
25%
Blood Platelets
25%
Calcium Channels
16%
CCAAT-Enhancer-Binding Protein-delta
26%
Cell Death
20%
Cyclic AMP
16%
Cyclization
37%
cycloartenol
14%
Drug Resistance
29%
Epoprostenol
17%
Esters
15%
Hydroxyzine
23%
Informed Consent
14%
Insecta
15%
Iodine-125
21%
IS 145
56%
Lactams
21%
Leukemia, Erythroblastic, Acute
19%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
31%
Membranes
14%
Myeloid Cells
46%
Myeloid Leukemia
18%
Nimodipine
15%
Oxidoreductases
27%
Phorbol Esters
16%
phorbol-12-myristate
17%
Plasminogen
17%
Poly(ADP-ribose) Polymerases
17%
Prostaglandin H2 Receptors Thromboxane A2
100%
protein kinase D2
29%
Ribosomal Protein S6
22%
Risk Reduction Behavior
15%
S 145
28%
Serine
14%
Site-Directed Mutagenesis
16%
Steroids
33%
Superoxide Dismutase-1
19%
Thromboxane A2
43%
Workplace
14%
Chemical Compounds
1,2,4-oxadiazole
43%
2,2-dimethylsuccinic Acid
21%
24-Methylenecycloartanol
14%
Agonist
16%
Alkylation
12%
Amide
17%
Amino Acid Amide
22%
Aniline
14%
Antagonist
32%
Antithrombocytic Agent
22%
Benzamidine
10%
Beraprost
7%
BMY 45778
8%
Chemical Transformation
9%
Curtius Rearrangement
10%
Cyclization Reaction
18%
Cycloartenol
12%
Enantiomer
11%
Epimerization
26%
Ester
9%
Estrogen
8%
Heptane
19%
Heptenoic Acid
28%
Imidazolidin-2-One
25%
Isoflavone
20%
Isoflavonoid
22%
Lactam
16%
Lanosterol
10%
Methyl Ester
6%
One Pot Reaction
13%
Phorbol 13-Acetate 12-Myristate
22%
Phorbol Ester
21%
Primary Amide
20%
Propionic Acid
16%
Prostaglandin
8%
Quantitative Yield
16%
Radioligand
16%
Reaction Yield
18%
Reduction
6%
Serine Residue
19%
Sodium Iodide
7%
Steroid
41%
Sulprostone
7%
Thromboxane
10%
Thromboxane A2
87%
Thromboxane A2 Receptor Blocking Agent
34%
Thromboxane Receptor Blocking Agent
53%
Toluene
11%